[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344688-105":59,"doc-detail-344688-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","timp1-as-a-context-dependent-biomarker-linking-cancer-progression-and-cardiovascular-disorders-a-multi-level-and-bioinformatics-study","TIMP1 as a context-dependent biomarker linking cancer progression and cardiovascular disorders - a multi-level and bioinformatics study","","Tissue inhibitor of metalloproteinase 1 (TIMP1) is studied as a context-dependent biomarker connecting cancer progression with cardiovascular disorders. An integrative bioinformatics pipeline combines microarray hub-gene discovery, pan-cancer analyses across TCGA/GTEx and public resources, and single-cell RNA-seq cell-type mapping, followed by targeted validation in cell line experiments. Findings are supported using immunohistochemistry, western blotting, and transwell assays in colorectal and gastric cancer models, with cardiovascular relevance assessed in atherosclerosis and heart-failure cohorts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/timp1-as-a-context-dependent-biomarker-linking-cancer-progression-and-cardiovascular-disorders-a-multi-level-and-bioinformatics-study/344688/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/timp1-as-a-context-dependent-biomarker-linking-cancer-progression-and-cardiovascular-disorders-a-multi-level-and-bioinformatics-study/344688.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does TIMP1 play in this study’s biomedical context?","Question",{"text":112,"@type":113},"TIMP1 is investigated for its diverse functions in extracellular matrix remodeling, immune regulation, and tumor progression, and for its potential connections to cardiovascular disease mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the main findings generated and validated?",{"text":117,"@type":113},"The study uses an integrative bioinformatics workflow (microarray, pan-cancer datasets, genomic/epigenetic/immune analyses, drug sensitivity profiling, and single-cell RNA-seq), then validates TIMP1 expression and function with cell line experiments and assays including immunohistochemistry, western blotting, and transwell experiments.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key cancer-related results for TIMP1?",{"text":121,"@type":113},"TIMP1 was upregulated across cancers, especially colorectal and gastric tumors, where it correlated with adverse survival and high diagnostic accuracy, and was linked to biological processes such as apoptosis, EMT, angiogenesis, and stromal–immune crosstalk.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344688,1790957067,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Original Research PUBLISHED 14 January 2026  \nDOI 10.3389/fimmu.2025.1699962  \nOPEN ACCESS  \nEDITED BY  \nGiuseppina Fanelli,  \nUniversity of Tuscia, Italy  \nREVIEWED BY  \nReza Eshraghi,  \nIsfahan University of Medical Sciences, Iran Federica Di Marco,  \nUniversity of Studies G. d’Annunzio Chieti and Pescara, Italy  \n*CORRESPONDENCE  \nZhenyang Fu  \n [fuzhy@mail3.sysu.edu.cn](fuzhy@mail3.sysu.edu.cn)[ ](fuzhy@mail3.sysu.edu.cn)Jianfang Luo  \n [luojianfang@sina.com](luojianfang@sina.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \n‡These authors have contributed equally to this work  \nRECEIVED 05 September 2025  \nREVISED 10 December 2025  \nACCEPTED 15 December 2025  \nPUBLISHED 14 January 2026  \nCITATION  \nXie H, Zhou D, Chen S, Dai Y, Zhang R, Lin Z, Kong W, Luo J and Fu Z (2026) TIMP1 as a context-dependent biomarker linking cancer progression and cardiovascular disorders: a multi-level and bioinformatics study.  \nFront. Immunol. 16:1699962 .  \ndoi: 10.3389/fimmu.2025.1699962  \nCOPYRIGHT  \n© 2026 Xie, Zhou, Chen, Dai, Zhang, Lin, Kong, Luo and Fu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTIMP1 as a context-dependent biomarker linking cancer progression and cardiovascular disorders: a multi-level and bioinformatics study  \nHaomin Xie 1,2†, Dianhua Zhou 3†, Sicheng Chen 1†, Yining Dai 3†, Ranran Zhang 4†, Zongrong Lin 2, Weiyi Kong 5, Jianfang Luo 3*‡ and Zhenyang Fu 6*‡  \n1 Department of Cardiovascular Disease, Shantou Hospital of Traditional Chinese Medicine, Shantou, China, 2The First Clinical Medical School of Guangdong Pharmaceutical University, Guangzhou, China, 3 Department of Cardiology, Guangdong Provincia People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China, 4 Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, Australia, 5Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, China, 6 Department of Cardiology, The First Afﬁliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China  \nBackground: Tissue inhibitor of metalloproteinase 1 (TIMP1) plays diverse roles in extracellular matrix (ECM) remodeling, immune regulation, and tumor progression. However, its systemic patterns across cancers and cardiovascular disease remain incompletely understood.  \nMethods: We applied an integrative pipeline beginning with microarray analysis of tumor-bearing mouse hearts (GSE63032) to identify TIMP1 as a hub gene. Pan-cancer datasets from TCGA/GTEx and public portals were analyzed for expression, genomic alterations, epigenetic regulation, immune inﬁltration, prognosis, and drug sensitivity. Single-cell RNA-seq was used to deﬁne cell type–speciﬁc expression. As all large-scale analyses were performed using publicly available bioinformatics datasets, cell line experiments were used for targeted validation of TIMP1 expression and function. Findings were validated by immunohistochemistry, western blotting, and transwell assays in colorectal and gastric cancer models, with additional analysis performed in atherosclerosis cohort (GSE100927) and heart failing cohort (GSE5406) to explore cardiovascular relevance.  \nResults: TIMP1 was consistently upregulated across cancers, especially in colorectal and gastric tumors, where it correlated with adverse survival and high diagnostic accuracy. Genomic analyses revealed copy number alterations, while promoter hypomethylation aligned with increased expression in digestive cancers","cbCaiqfgHLMOgcgj","https://ap.wps.com/l/cbCaiqfgHLMOgcgj","pdf",24595551,23,"English","# Background\n# Methods\n# Results\n# Conclusion\n# KEYWORDS\n# 1 Introduction","[{\"question\":\"What role does TIMP1 play in this study’s biomedical context?\",\"answer\":\"TIMP1 is investigated for its diverse functions in extracellular matrix remodeling, immune regulation, and tumor progression, and for its potential connections to cardiovascular disease mechanisms.\"},{\"question\":\"How were the main findings generated and validated?\",\"answer\":\"The study uses an integrative bioinformatics workflow (microarray, pan-cancer datasets, genomic/epigenetic/immune analyses, drug sensitivity profiling, and single-cell RNA-seq), then validates TIMP1 expression and function with cell line experiments and assays including immunohistochemistry, western blotting, and transwell experiments.\"},{\"question\":\"What were the key cancer-related results for TIMP1?\",\"answer\":\"TIMP1 was upregulated across cancers, especially colorectal and gastric tumors, where it correlated with adverse survival and high diagnostic accuracy, and was linked to biological processes such as apoptosis, EMT, angiogenesis, and stromal–immune crosstalk.\"}]","TIMP1 as a context-dependent biomarker linking cancer progression and cardiovascular disorders - a multi-level and bioinformatics study | PDF",1790054936,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/142db912362807dfed3b05fbf0d717dc.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/868a514a03b708f87484a29513115832.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f66a4603a427ec140c90352445cf0d11.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e2ce6c221f01711ec061de27c0026fa.webp",980,1385]